Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib.

Journal of Experimental & Clinical Cancer Research : CR
Lokesh JainWilliam D Figg

Abstract

Hypertension (HT) and hand-foot skin reactions (HFSR) may be related to the activity of bevacizumab and sorafenib. We hypothesized that these toxicities would correspond to favorable outcome in these drugs, that HT and HFSR would coincide, and that VEGFR2 genotypic variation would be related to toxicity and clinical outcomes. Toxicities (> or = grade 2 HT or HFSR), progression-free survival (PFS), and overall survival (OS) following treatment initiation were evaluated. Toxicity incidence and VEGFR2 H472Q and V297I status were compared to clinical outcomes. Individuals experiencing HT had longer PFS following bevacizumab therapy than those without this toxicity in trials utilizing bevacizumab in patients with prostate cancer (31.5 vs 14.9 months, n = 60, P = 0.0009), and bevacizumab and sorafenib in patients with solid tumors (11.9 vs. 3.7 months, n = 27, P = 0.052). HT was also linked to a > 5-fold OS benefit after sorafenib and bevacizumab cotherapy (5.7 versus 29.0 months, P = 0.0068). HFSR was a marker for prolonged PFS during sorafenib therapy (6.1 versus 3.7 months respectively, n = 113, P = 0.0003). HT was a risk factor for HFSR in patients treated with bevacizumab and/or sorafenib (OR(95%CI) = 3.2(1.5-6.8), P = 0.0024). ...Continue Reading

Associated Clinical Trials

References

Sep 22, 2001·Endocrine-related Cancer·J F LyonsG Bollag
Nov 13, 2004·The Lancet Oncology·Ed Susman
Jan 24, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D StrumbergB Schwartz
Aug 21, 2007·Journal of the American College of Cardiology·Yibo WangRutai Hui
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tristan M SissungWilliam D Figg
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nilofer S AzadElise C Kohn
Oct 10, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ScartozziS Cascinu
Jan 22, 2009·BJU International·Jeanny B Aragon-ChingWilliam L Dahut
Feb 21, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nilofer S AzadHeidi H Kong
Mar 6, 2009·The Annals of Pharmacotherapy·Sarah M Gressett, Sachin R Shah
Apr 4, 2009·Anti-cancer Drugs·Vincent Launay-Vacher, Gilbert Deray
Sep 25, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Siegfried SegaertSabine Tejpar
Sep 25, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·César Gómez-RaposoAndrés Redondo
Mar 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yang-Min NingWilliam L Dahut
Jan 13, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ronan J KellyGiuseppe Giaccone

❮ Previous
Next ❯

Citations

Oct 3, 2012·The Lancet Oncology·Bryan P SchneiderKathy D Miller
Jan 31, 2012·The Oncologist·Isabelle Ray-CoquardUNKNOWN French Sarcoma Group (GSF/GETO)
Nov 29, 2011·Pharmacogenomics·Torben Frøstrup Hansen, Anders Jakobsen
Nov 15, 2012·Pharmacogenomics·Cristina Rodríguez-Antona, Jesús García-Donas
Apr 29, 2014·Clinical Oncology : a Journal of the Royal College of Radiologists·M AjazA Chalmers
Aug 15, 2014·British Journal of Cancer·B P SchneiderG W Sledge
Mar 2, 2013·Molecular & Cellular Proteomics : MCP·Nilofer AzadElise C Kohn
Aug 27, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Grace K DyAlex A Adjei
May 8, 2014·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Manabu MorimotoKatsuaki Tanaka
Oct 20, 2012·European Journal of Clinical Investigation·Shao-Jung HsuShou-Dong Lee
Mar 14, 2014·The Journal of Clinical Hypertension·Yan LiBenkang Shi
Dec 17, 2014·Basic & Clinical Pharmacology & Toxicology·Ye LiXian-Jun Qu
May 30, 2012·Journal of Experimental & Clinical Cancer Research : CR·Gabriella FabbrociniGiuseppe Monfrecola
Jun 3, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B McLellanE Van Cutsem
Jun 13, 2012·Biological & Pharmaceutical Bulletin·Yuichiro AzumaHiroshi Yamamoto
Feb 6, 2014·Urologic Oncology·Jesus Garcia-DonasCristina Rodriguez-Antona
Dec 21, 2013·Critical Reviews in Oncology/hematology·Rim S IshakFadi S Farhat
Nov 19, 2013·Urologic Oncology·Guru Sonpavde, Toni K Choueiri
Aug 27, 2013·Seminars in Oncology·M Dror Michaelson, Walter M Stadler
Aug 27, 2013·Seminars in Oncology·Jesus Garcia-DonasEric Jonasch
Nov 22, 2014·Cancer Chemotherapy and Pharmacology·Aaron T WeckslerBruce D Hammock
Aug 18, 2016·Pharmacogenomics·Sander BinsRon Hj Mathijssen
Apr 9, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vinay PrasadTito Fojo
May 11, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bryan P Schneider, George W Sledge
Apr 1, 2017·Pharmacogenetics and Genomics·Li GongTeri E Klein
Mar 2, 2016·Therapeutic Advances in Gastroenterology·Alessandro GranitoLuigi Bolondi
Oct 3, 2014·World Journal of Hepatology·Masako ShomuraTetsuya Mine
Jun 19, 2018·Expert Opinion on Pharmacotherapy·Shun Yamamoto, Shunsuke Kondo
Jan 20, 2018·Endocrine-related Cancer·Tirtha K Das, Ross L Cagan
Jul 7, 2012·British Journal of Cancer·N PécuchetF Goldwasser
Aug 23, 2019·International Journal of Molecular Medicine·Nora M SchacherKatharina Urschel
May 11, 2017·Cancer Chemotherapy and Pharmacology·Tristan M SissungWilliam D Figg
Apr 25, 2020·International Journal of Molecular Sciences·Jose J G MarinMarta R Romero

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
PCR

Clinical Trials Mentioned

NCT00093431
NCT00091364
NCT00100763
NCT00343772
NCT00098592
NCT00304122

Software Mentioned

SAS

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.